A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is a 12-week, double-blind, placebo-controlled, randomized, parallel-group, multicenter study of the safety and efficacy of JZP385 in the treatment of adult participants with moderate to severe ET.
Epistemonikos ID: 3236107a57d69d1487c5c9fc60955f105de8c775
First added on: May 09, 2024